Lv417
540 积分 2023-08-25 加入
Pyrotinib and Trastuzumab Plus Chemotherapy Serve as an Acceptable Neoadjuvant Regimen Exhibiting Good Efficacy and Tolerance in HER2-Positive Breast Cancer Patients
1天前
待确认
Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors
4天前
已关闭
A randomized double-blind multicenter phase III study offixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
4天前
已关闭
Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer
4天前
已关闭
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim inchemotherapy-induced neutropenia: a multicenterdose-finding study in women with breast cancer
4天前
已关闭
The five “Ws” for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs)
10天前
已完结
Pain in Trauma Patients: Measurement and Predisposing Factors
15天前
已完结
Familiarity of surgical teams: Impact on laparoscopic procedure time
20天前
已完结
Hyperglycosylation of prosaposin in tumor dendritic cells drives immune escape
29天前
已完结
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial
1个月前
已完结
皖公网安备34019202002308
